跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XARELTO rivaroxaban 2.5 mg film-coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
XARELTO rivaroxaban 2.5 mg film-coated tablet blister pack
Approved
STANDARD
XARELTO rivaroxaban 2.5 mg film-coated tablet blister pack
Bayer Australia Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
3b6ce90564cb7125
Company
Bayer Australia Ltd
Type
Standard
Approval Details
Approval Id
3b6ce90564cb7125
Product Name
XARELTO rivaroxaban 2.5 mg film-coated tablet blister pack
Artg Id
298198
Artg Name
XARELTO rivaroxaban 2.5 mg film-coated tablet blister pack
Sponsor
Bayer Australia Ltd
Company Detail Path
/organization/bayer-australia-ltd
Artg Date
2019-01-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/149510ebe1c371421442bf39108d51b5.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/209a418b6e9edc39acdc11f84b63aeed.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
3b6ce90564cb7125
Type
Standard
Back to TGA Approvals